Quarterly Metrics: Quick and Current Ratios for Dyne Therapeutics Inc (DYN)

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Dyne Therapeutics Inc’s stock clocked out at $44.88, down -3.55% from its previous closing price of $46.53. In other words, the price has decreased by -$3.55 from its previous closing price. On the day, 0.97 million shares were traded. DYN stock price reached its highest trading level at $46.16 during the session, while it also had its lowest trading level at $44.69.

Ratios:

To gain a deeper understanding of DYN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 26.63 and its Current Ratio is at 26.63. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on May 21, 2024, Reiterated its Buy rating but revised its target price to $42 from $31 previously.

On April 30, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $40.

On February 20, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $36.H.C. Wainwright initiated its Buy rating on February 20, 2024, with a $36 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 22 ’24 when Kersten Dirk sold 95,321 shares for $45.82 per share. The transaction valued at 4,368,083 led to the insider holds 805,549 shares of the business.

Kersten Dirk sold 85,088 shares of DYN for $3,934,005 on Aug 23 ’24. The Director now owns 720,461 shares after completing the transaction at $46.23 per share. On Aug 21 ’24, another insider, Kersten Dirk, who serves as the Director of the company, sold 135,763 shares for $46.78 each. As a result, the insider received 6,350,605 and left with 900,870 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 4671649280 and an Enterprise Value of 3752866816.

Stock Price History:

Over the past 52 weeks, DYN has reached a high of $47.45, while it has fallen to a 52-week low of $6.40. The 50-Day Moving Average of the stock is 11.39%, while the 200-Day Moving Average is calculated to be 70.51%.

Shares Statistics:

It appears that DYN traded 1.08M shares on average per day over the past three months and 961810 shares per day over the past ten days. A total of 100.40M shares are outstanding, with a floating share count of 73.76M. Insiders hold about 26.54% of the company’s shares, while institutions hold 84.32% stake in the company. Shares short for DYN as of 1722384000 were 9881196 with a Short Ratio of 9.16, compared to 1719532800 on 9076068. Therefore, it implies a Short% of Shares Outstanding of 9881196 and a Short% of Float of 11.85.

Most Popular